WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 585202
CAS#: 5027-63-4
Description: Saccharolactone is used as index for assessing induction of hepatic enzymes by anticonvulsants.
MedKoo Cat#: 585202
Name: Saccharolactone
CAS#: 5027-63-4
Chemical Formula: C7H8O5
Exact Mass: 172.0372
Molecular Weight: 172.136
Elemental Analysis: C, 48.84; H, 4.68; O, 46.47
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Saccharolactone
IUPAC/Chemical Name: 1,4-Glucarolactone
InChi Key: JHKOIGAXFKOJJB-PUFIMZNGSA-N
InChi Code: InChI=1S/C7H8O5/c8-2-5-6-3(9)1-4(11-5)7(10)12-6/h1,3,5-6,8-9H,2H2/t3-,5-,6+/m1/s1
SMILES Code: O[C@@H]1C=C2O[C@H](CO)[C@H]1OC2=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 172.136 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: BOYLAND E, WALLACE DM, WILLIAMS. Enzyme activity in relation to cancer: inhibition of urinary beta-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds. Br J Cancer. 1957 Dec;11(4):578-89. PubMed PMID: 13510516; PubMed Central PMCID: PMC2073720.
2: Gourley GR, Gourley MF, Arend R, Palta M. The effect of saccharolactone on rat intestinal absorption of bilirubin in the presence of human breast milk. Pediatr Res. 1989 Mar;25(3):234-8. PubMed PMID: 2704588.
3: Oleson L, Court MH. Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. J Pharm Pharmacol. 2008 Sep;60(9):1175-82. doi: 10.1211/jpp.60.9.0009. PubMed PMID: 18718121; PubMed Central PMCID: PMC2697495.
4: Pellock SJ, Walton WG, Biernat KA, Torres-Rivera D, Creekmore BC, Xu Y, Liu J, Tripathy A, Stewart LJ, Redinbo MR. Three structurally and functionally distinct β-glucuronidases from the human gut microbe Bacteroides uniformis. J Biol Chem. 2018 Nov 30;293(48):18559-18573. doi: 10.1074/jbc.RA118.005414. Epub 2018 Oct 9. PubMed PMID: 30301767; PubMed Central PMCID: PMC6290157.
5: Kushinsky S, Chen VL. The inhibition of beta-glucuronidase from bovine liver by 1,4-saccharolactone. Comp Biochem Physiol. 1967 Feb;20(2):535-42. PubMed PMID: 6035560.
6: Dai P, Zhu L, Luo F, Lu L, Li Q, Wang L, Wang Y, Wang X, Hu M, Liu Z. Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. AAPS J. 2015 May;17(3):723-36. doi: 10.1208/s12248-015-9732-x. Epub 2015 Mar 12. PubMed PMID: 25762448; PubMed Central PMCID: PMC4406953.
7: Argikar UA. Saccharolactone: The History, the Myth, and the Practice. Curr Drug Metab. 2018;19(4):304-309. doi: 10.2174/1389200219666171229232007. Review. PubMed PMID: 29298647.
8: Xie B, Liu A, Zhan X, Ye X, Wei J. Alteration of gut bacteria and metabolomes after glucaro-1,4-lactone treatment contributes to the prevention of hypercholesterolemia. J Agric Food Chem. 2014 Jul 30;62(30):7444-51. doi: 10.1021/jf501744d. Epub 2014 Jul 14. PubMed PMID: 24972288.
9: Yang W, Zhou G, Zou S, Yang W, Liu A, Sun S, Xie B. Metabonomics of d-glucaro-1,4-lactone in preventing diethylnitrosamine-induced liver cancer in rats. Pharm Biol. 2018 Dec;56(1):643-648. doi: 10.1080/13880209.2018.1525414. PubMed PMID: 31070541; PubMed Central PMCID: PMC6292356.
10: Xie B, Liu Y, Zou H, Son Y, Wang H, Wang H, Shao J. Determination of D-glucaric acid and/or D-glucaro-1,4-lacton in different apple varieties through hydrophilic interaction chromatography. Food Chem. 2016 Jul 15;203:1-7. doi: 10.1016/j.foodchem.2016.02.009. Epub 2016 Feb 2. PubMed PMID: 26948581.
11: Brunelle FM, Verbeeck RK. Glucuronidation of diflunisal by rat liver microsomes. Effect of microsomal beta-glucuronidase activity. Biochem Pharmacol. 1993 Dec 3;46(11):1953-8. PubMed PMID: 8267644.
12: Zółtaszek R, Hanausek M, Kiliańska ZM, Walaszek Z. [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. Postepy Hig Med Dosw (Online). 2008 Sep 5;62:451-62. Review. Polish. PubMed PMID: 18772850.
13: Saluk-Juszczak J, Olas B, Nowak P, Staroń A, Wachowicz B. Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. Nutr Metab Cardiovasc Dis. 2008 Jul;18(6):422-8. Epub 2007 Oct 22. PubMed PMID: 17933501.
14: Coddington KA, Swanson SP, Hassan AS, Buck WB. Enterohepatic circulation of T-2 toxin metabolites in the rat. Drug Metab Dispos. 1989 Nov-Dec;17(6):600-5. PubMed PMID: 2575494.
15: Xia B, Zhou Q, Zheng Z, Ye L, Hu M, Liu Z. A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut. Mol Pharm. 2012 Nov 5;9(11):3246-58. doi: 10.1021/mp300315d. Epub 2012 Oct 24. PubMed PMID: 23033922; PubMed Central PMCID: PMC3953453.
16: Peyrol J, Meyer G, Obert P, Dangles O, Pechère L, Amiot MJ, Riva C. Involvement of bilitranslocase and beta-glucuronidase in the vascular protection by hydroxytyrosol and its glucuronide metabolites in oxidative stress conditions. J Nutr Biochem. 2018 Jan;51:8-15. doi: 10.1016/j.jnutbio.2017.09.009. Epub 2017 Oct 3. PubMed PMID: 29078076.
17: Xie B, Zhang Z, Gong T, Zhang N, Wang H, Zou H. Application of metabonomic strategy to discover an unreported active ingredient in LiuWeiDiHuang pills suppressing beta-glucuronidase. Anal Bioanal Chem. 2015 Jan;407(2):609-14. doi: 10.1007/s00216-014-8253-2. Epub 2014 Nov 9. PubMed PMID: 25381611.
18: Menendez C, Dueñas M, Galindo P, González-Manzano S, Jimenez R, Moreno L, Zarzuelo MJ, Rodríguez-Gómez I, Duarte J, Santos-Buelga C, Perez-Vizcaino F. Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? Mol Nutr Food Res. 2011 Dec;55(12):1780-90. doi: 10.1002/mnfr.201100378. PubMed PMID: 22144045.
19: Yuen S. [The effect of saccharolactone on the beta-glucuronidase activity of rat organs and rabbit blood]. Kobe Ika Daigaku Kiyo. 1964 Mar;26(1):5-8. Japanese. PubMed PMID: 5294341.
20: Kowalczyk MC, Spears E, Narog M, Zoltaszek R, Kowalczyk P, Hanausek M, Yoshimi N, Slaga TJ, Walaszek Z. Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors. Oncol Rep. 2011 Sep;26(3):551-6. doi: 10.3892/or.2011.1351. Epub 2011 Jun 17. PubMed PMID: 21687956.
